PCI 29732

PCI 29732是不可逆的Btk抑制剂,IC50为8.2 nM。

信号通路 >> 蛋白酪氨酸激酶 >> BTK

研究领域 >> 炎症/免疫

[1]. Pan Z, et al. Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase. ChemMedChem. 2007 Jan;2(1):58-61.

[2]. Honigberg LA, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80.

阿卡拉布替尼(ACP-196) | Fenebrutinib | 依伏替尼 | 司培替尼 | (±)-Zanubrutinib | (R)-6-氨基-9-(1-(丁-2-炔酰基)吡咯烷-3-基)-7-(4-苯氧基苯基)-7H-嘌呤-8(9H)-酮 | N-[2-甲基-5-[9-[4-[(甲基磺酰基)氨基]苯基]-2-氧代苯并[H]-1,6-萘啶-1(2H)-基]苯基]-2-丙烯酰胺 | GDC-0834 | BTK IN-1 | RN486 | (2Z)-2-氰基-N-(2,5-二溴苯基)-3-羟基-2-丁烯酰胺 | Vecabrutinib | N-[3-[4,5-二氢-4-甲基-6-[[4-(4-吗啉基羰基)苯基]氨基]-5-氧代-2-吡嗪基]-2-甲基苯基]-4-(叔丁基)苯甲酰胺 | BMS-986195 | CNX-774